• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[银屑病中肽水解酶和胰蛋白酶抑制剂的活性]

[Activity of peptide hydrolases and trypsin inhibitor in psoriasis].

作者信息

Suvorov A P

出版信息

Vopr Med Khim. 1982 Nov-Dec;28(6):81-3.

PMID:6760540
Abstract

Distinct activation of alkaline and trypsinlike proteinases, leucine aminopeptidase as well as inhibition of the antitryptic activity (ATA) occurred in the area of impaired skin and in peripheral blood of patients with psoriasis as shown by clinico-laboratory examinations. These data suggest the epidermal origin of the substance inhibiting the enzymatic activity. After administration into animals of homogenates of impaired skin obtained from the patients an increase in BAEE-esterase activity and a decrease in the ATA were observed in blood serum. A reverse correlation was found between the ATA of parakeratotic layer and amount of eosinophils in peripheric blood.

摘要

临床实验室检查显示,银屑病患者受损皮肤区域和外周血中碱性蛋白酶、类胰蛋白酶、亮氨酸氨肽酶有明显激活,同时抗胰蛋白酶活性(ATA)受到抑制。这些数据提示抑制酶活性物质的表皮来源。将患者受损皮肤匀浆注入动物后,血清中BAEE酯酶活性增加,ATA降低。角化不全层的ATA与外周血嗜酸性粒细胞数量呈负相关。

相似文献

1
[Activity of peptide hydrolases and trypsin inhibitor in psoriasis].[银屑病中肽水解酶和胰蛋白酶抑制剂的活性]
Vopr Med Khim. 1982 Nov-Dec;28(6):81-3.
2
[Regulation of peptide hydrolase activity in psoriasis].[银屑病中肽水解酶活性的调节]
Dermatol Monatsschr. 1990;176(7):393-7.
3
[Kallikrein and prekallikrein content and antitryptic activity in the blood serum in serum hepatitis of varying degrees of severity].[不同严重程度血清性肝炎患者血清中激肽释放酶和前激肽释放酶含量及抗胰蛋白酶活性]
Vopr Med Khim. 1981 Nov-Dec;27(6):804-11.
4
[Effect of proteolysis inhibitors on serum proteinase activity and its antitryptic activity in postischemic toxemia].[蛋白水解抑制剂对缺血后毒血症中血清蛋白酶活性及其抗胰蛋白酶活性的影响]
Farmakol Toksikol. 1978 Nov-Dec;41(6):693-6.
5
[Change in proteolytic enzymatic activity in the blood serum in children with chronic diseases of the digestive organs].[消化器官慢性疾病患儿血清中蛋白水解酶活性的变化]
Vopr Pitan. 1980 Jul-Aug(4):42-5.
6
[Blood serum activity of certain proteases and alkaline protease inhibitor in healthy children].[健康儿童血清中某些蛋白酶和碱性蛋白酶抑制剂的活性]
Vopr Okhr Materin Det. 1973 Oct;18(10):45-7.
7
[Activity of proteolytic enzymes and trypsin inhibitor in blood serum and kidney in pyelonephritis].[肾盂肾炎患者血清及肾脏中蛋白水解酶和胰蛋白酶抑制剂的活性]
Vopr Med Khim. 1975 Sep-Oct;21(5):538-42.
8
[Proteolytic activity and trypsin inhibitor content in the blood serum in nonspecific lung diseases].[非特异性肺部疾病患者血清中的蛋白水解活性及胰蛋白酶抑制剂含量]
Sov Med. 1978 Apr(4):60-4.
9
[Proteolytic activity and content of trypsin inhibitor in the blood serum of patients with leukemia].[白血病患者血清中的蛋白水解活性及胰蛋白酶抑制剂含量]
Lab Delo. 1973;9:546-9.
10
[Quantitative characteristics of serum antitryptic activity].[血清抗胰蛋白酶活性的定量特征]
Ukr Biokhim Zh. 1977 Mar-Apr;49(2):113-6.